News | August 28, 2009

Resonant Exhibits Next Gen Radiotherapy System at ESTRO

August 28, 2009 - Resonant Medical, an innovator in soft tissue planning, image-guidance and adaptive radiotherapy products, will be exhibiting the next generation of its multi-anatomy Clarity System at the 10th Biennial Meeting of The European Society of Therapeutic Radiology and Oncologists (ESTRO), being held in Maastricht, Netherlands.

Clarity provides soft tissue hybrid imaging, integrated within the CT Suite. Clarity also provides structure based image-guided radiotherapy (IGRT) during daily radiation treatments. The next generation version of Clarity also supports adaptive radiotherapy by alerting physicians of changes in a target structure’s precise location, shape and size and enabling them to use this information to adapt the patient’s treatment plan as necessary. Additionally, the MAASTRO Clinic in Maastricht has begun offering the Clarity System for its prostate and breast treatments.

During the radiation treatment planning phase, Clarity allows physicians to automatically compare CT and 3D ultrasound images acquired at the same time with the patient in the same position, which can dramatically improve the treatment planning workflow when compared to CT alone. The Clarity System is based on daily auto-contouring and true 3D anatomy changes during the entire course of treatment, ensuring rapid and precise daily delivery to the intended target while sparing healthy tissue. Clarity’s 3D ultrasound imaging is a gentle, non-invasive technology most often associated with pregnancy and providing images of babies. In addition to adding the Clarity System to treatment for breast and prostate cancer patients, physicians at MAASTRO will be exploring how the system may improve treatment planning and targeting in GYN, bladder and liver cancer patients.

For more information: and

Related Content

RayStation Selected for New Carbon Ion Therapy Center in Japan
News | Treatment Planning | January 18, 2018
January 18, 2018 – RayStation has been chosen as the treatment planning system for a new carbon-ion therapy facility
Raysearch Receives First Order for the Raycare Oncology Information System
News | Oncology Information Management Systems (OIMS) | January 18, 2018
January 18, 2018 – Anderson Regional Cancer Center (ARCC) in Meridian, Mississippi, has placed the first order for...
Mevion Receives 510(k) Clearance for Hyperscan Pencil Beam Scanning Proton Therapy
Technology | Proton Therapy | January 04, 2018
Mevion Medical Systems has received U.S. Food and Drug Administration (FDA) 510(k) clearance for the Mevion S250i...
Study Compares Radiosurgery and Whole-Brain Radiation in Lung Cancer Patients With Multiple Brain Metastases
News | Radiation Therapy | January 03, 2018
Although targeted therapies have produced dramatic advances in the ability to control some types of advanced lung...
MEDraysintell Downgrades Proton Therapy Market Projection for 2030
News | Proton Therapy | January 02, 2018
MEDraysintell recently downgraded its projection for proton therapy rooms expected to be operational in 2030 from 1,200...
California US Oncology Network Centers Adopt Xoft Electronic Brachytherapy System for Early-Stage Non-Melanoma Skin Cancer
News | Brachytherapy Systems | January 02, 2018
iCAD Inc. announced that its Xoft Axxent Electronic Brachytherapy (eBx) System is now available at two California-based...
Blue Phantom System Used for Acceptance of First European Varian Halcyon Machine
News | Radiation Therapy | January 02, 2018
IBA (Ion Beam Applications S.A.) announced in November the acceptance and beam model validation of the first Varian...
Study Finds Link Between Breast Cancer Treatments and Cellular Aging Markers
News | Women's Health | January 02, 2018
January 2, 2018 — A new study found women who had received chemotherapy and/or...
ACR Appropriateness Criteria Adds and Revises Topics for December 2017
News | Clinical Decision Support | December 29, 2017
December 29, 2017 — Radiologists can enhance the quality and effectiveness of care with the newest release of the ACR
FDA Clears GammaPod Stereotactic Radiotherapy System for Breast Cancer Treatment
Technology | Stereotactic Body Radiation Therapy (SBRT) | December 22, 2017
The U.S. Food and Drug Administration (FDA) has cleared the new GammaPod noninvasive stereotactic radiotherapy system...
Overlay Init